Geberit : FY net CHF 355m (vs cons CHF 359m) / EBIT CHF 482.2m (vs cons CHF 492m) Outlook: expects solid sales growth and further EPS growth in ’07 ? to raise dividend to CHF 40 (BB)

Panalpina : FY sales CHF 7.735bn (vs cons CHF 7.847bn) / EBIT CHF 261m (vs cons CHF 251m) / net profit 183.5m (vs cons 176.7m) Outlook: to raise dividend to CHF 3.00 ? says ?momentum at early ’07 confirms positive outlook (BB)

Vontobel : FY revenues CHF 840.2m (vs cons CHF 814.6m) / costs CHF 506.4m (vs cons CHF 476.4m) / net profit CHF 259.5m (vs cons CHF 246.5m) / AuM CHF 71.2bn (vs cons CHF 67.5bn) Outlook: raises dividend to CHF 2.00 (BB)

Kuoni : FY sales CHF 4.08bn (vs cons CHF 4.04bn) / EBIT CHF 121.7m (vs cons CHF 122.8m) / net profit CHF 116.7m (vs cons CHF 109.9m) Outlook: to pay dividend of CHF 3.00 ? aims to grow above market ? says its big enough to remain independent (BB)

Unique : FY sales 737.1m (vs cons CHF 739.2m) / EBIT CHF 189.4m (vs cons CHF 190.8m) / net profit CHF 87.5m (vs cons CHF 83.4m) Outlook: expects similar passenger growth for ’07 ? to raise dividend to CHF 3.00 (BB)

Medisize : FY sales CHF 249.9m (vs CHF 259m) / EBIT CHF 30.1m (vs CHF 31.4m) / net profit CHF 22.6m (vs cons CHF 23m) Outlook: says full year net rises 25% on dental sales ? to pay dividend of CHF 1.60 (BB)

Novartis : Barron’s Online reports Novartis’ drug pipeline remains one of the industry’s strongest, capable of launching eight new products by 2008 (Barron’s)

Logitech : accelerated repurchasing its shares this year and will remain ?prudent? in making acquisitions ? sees further acquisitions in ?digital home? area (BB)